Meta‐analysis: Saccharomyces boulardii for treating acute diarrhoea in children
Authors:
- 8 January 2007
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 25 (3) , 257-264
Abstract
Summary: Background: Saccharomyces boulardii is a non‐pathogenic probiotic yeast considered useful against enteropathogens.Aim: To assess the effectiveness of S. boulardii in treating acute infectious diarrhoea in children.Methods: The following electronic databases were searched through August 2006 for studies relevant to acute infectious diarrhoea and S. boulardii: MEDLINE, EMBASE, CINAHL and The Cochrane Library; additional references were obtained from reviewed articles. Only randomized‐controlled trials were included.Results: Five randomized‐controlled trials (619 participants) met the inclusion criteria. Combined data from four randomized‐controlled trials showed that S. boulardii significantly reduced the duration of diarrhoea compared with control. The pooled weighted mean difference was −1.1 days (95% CI: −1.3 to −0.8) with a fixed model and remained significant in a random effect model. Saccharomyces boulardii significantly reduced the risk of diarrhoea on days 3, 6 and 7. Also the risk of diarrhoea lasting >7 days was significantly reduced in the S. boulardii group vs. control group (1 RCT, n = 88, RR 0.25, 95% CI: 0.08–0.83; NNT 5, 95% CI: 3–20).Conclusions: There exists a moderate clinical benefit of S. boulardii therapy in otherwise healthy infants and children with acute gastroenteritis, mainly a shorter duration of diarrhoea. However, these results should be interpreted with caution due to methodological limitations of the included studies.Keywords
This publication has 19 references indexed in Scilit:
- Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expressionBiochemical and Biophysical Research Communications, 2006
- Meta‐analysis: non‐pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoeaAlimentary Pharmacology & Therapeutics, 2005
- Effects of Saccharomyces boulardii in children with acute diarrhoeaActa Paediatrica, 2005
- Probiotics for treating infectious diarrhoea2003
- Saccharomyces boulardiiStimulates Intestinal Immunoglobulin A Immune Response toClostridium difficileToxin A in MiceInfection and Immunity, 2001
- Implication of Mitogen-Activated Protein Kinases in T84 Cell Responses to EnteropathogenicEscherichia coliInfectionInfection and Immunity, 2001
- ProbioticsInternational Journal of Food Microbiology, 1998
- Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic miceJournal of Applied Bacteriology, 1996
- Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileumGastroenterology, 1993
- Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated withSaccharomyces boulardiiDigestive Diseases and Sciences, 1990